219 related articles for article (PubMed ID: 16109084)
1. Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: an update on approaches to management.
Little MA; Pusey CD
Nephrology (Carlton); 2005 Aug; 10(4):368-76. PubMed ID: 16109084
[TBL] [Abstract][Full Text] [Related]
2. Anti-neutrophil cytoplasm-associated glomerulonephritis.
Morgan MD; Harper L; Williams J; Savage C
J Am Soc Nephrol; 2006 May; 17(5):1224-34. PubMed ID: 16624931
[TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Gaskin G; Pusey CD
Ther Apher; 2001 Jun; 5(3):176-81. PubMed ID: 11467753
[TBL] [Abstract][Full Text] [Related]
4. Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment.
Zaenker M; Arbach O; Helmchen U; Glorius P; Ludewig S; Braasch E
Int J Tissue React; 2004; 26(3-4):85-92. PubMed ID: 15648440
[TBL] [Abstract][Full Text] [Related]
5. [Hypertrophic pachymeningitis, glomerulonephritis and P-ANCA associated small vessel vasculitis].
Mazzocchi O; Risso JA; Viozzi F; Apa NP; Peralba MC; Nadal MA; De Rosa GE
Medicina (B Aires); 2007; 67(2):151-5. PubMed ID: 17593600
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects of therapy for ANCA-associated vasculitis.
Turnbull J; Harper L
Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):391-401. PubMed ID: 19508946
[TBL] [Abstract][Full Text] [Related]
7. Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis.
Hotta O; Ishida A; Kimura T; Taguma Y
Ther Apher Dial; 2006 Oct; 10(5):390-5. PubMed ID: 17096692
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
Kallenberg CG
Curr Opin Rheumatol; 2007 Jan; 19(1):17-24. PubMed ID: 17143091
[TBL] [Abstract][Full Text] [Related]
9. Lung transplantation for severe antineutrophilic cytoplasmic antibody-associated vasculitis.
Weinkauf J; Puttagunta L; Stewart K; Humar A; Homik J; Caldwell S; Fenton M; Nador R; Lien D
Transplant Proc; 2010 Sep; 42(7):2707-10. PubMed ID: 20832574
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
Feldmann M; Pusey CD
J Am Soc Nephrol; 2006 May; 17(5):1243-52. PubMed ID: 16624928
[TBL] [Abstract][Full Text] [Related]
11. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
Kötter I
Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987
[No Abstract] [Full Text] [Related]
12. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Jennette JC; Falk RJ
Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858
[TBL] [Abstract][Full Text] [Related]
13. Treatment of ANCA-associated systemic vasculitis.
Belmont HM
Bull NYU Hosp Jt Dis; 2006; 64(1-2):60-6. PubMed ID: 17121492
[TBL] [Abstract][Full Text] [Related]
14. Systemic vasculitis: still a challenging disease.
Buhaescu I; Covic A; Levy J
Am J Kidney Dis; 2005 Aug; 46(2):173-85. PubMed ID: 16112036
[TBL] [Abstract][Full Text] [Related]
15. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
[TBL] [Abstract][Full Text] [Related]
16. Recent advances to achieve remission induction in antineutrophil cytoplasmic antibody-associated vasculitis.
Harper L
Curr Opin Rheumatol; 2010 Jan; 22(1):37-42. PubMed ID: 19770660
[TBL] [Abstract][Full Text] [Related]
17. Challenges in the management of microscopic polyangiitis: past, present and future.
Jayne D
Curr Opin Rheumatol; 2008 Jan; 20(1):3-9. PubMed ID: 18281850
[TBL] [Abstract][Full Text] [Related]
18. Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials.
Vanková Z; Ríhová Z; Jancová E; Rysavá R; Merta M; Tesar V
Prague Med Rep; 2006; 107(2):199-212. PubMed ID: 17066740
[TBL] [Abstract][Full Text] [Related]
19. Rapidly progressive glomerulonephritis: current and evolving treatment strategies.
Little MA; Pusey CD
J Nephrol; 2004; 17 Suppl 8():S10-9. PubMed ID: 15599880
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous vasculitis: diagnosis and management.
Carlson JA; Cavaliere LF; Grant-Kels JM
Clin Dermatol; 2006; 24(5):414-29. PubMed ID: 16966021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
